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Key Points Summary 
x Reduced carbohydrate (CHO) availability before and after exercise may 
augment endurance training-induced adaptations of human skeletal muscle, as 
mediated via modulation of cell signalling pathways.  
x However, it is not known whether such responses are mediated by CHO 
restriction, energy restriction or a combination of both. 
x In recovery from a twice per day training protocol where muscle glycogen 
concentration is maintained within 200-350 mmol.kg-1 dw, we demonstrate 
acute post-exercise CHO and energy restriction (i.e. <24 hours) does not 
potentiate potent cell signalling pathways that regulate hallmark adaptations 
associated with endurance training.  
x In contrast, consuming CHO before, during and after an acute training session 
attenuated markers of bone resorption, effects that are independent of energy 
availability. 
x Whilst the enhanced muscle adaptations associated with CHO restriction may 
be regulated by absolute muscle glycogen concentration, the acute within day 
fluctuations in CHO availability inherent to twice per day training may have 
chronic implications for bone turnover. 
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Abstract 
We examined the effects of post-exercise carbohydrate (CHO) and energy availability 
(EA) on potent skeletal muscle cell signalling pathways (regulating mitochondrial 
biogenesis and lipid metabolism) and indicators of bone metabolism.  In a repeated 
measures design, nine males completed a morning (AM) and afternoon (PM) high-
intensity interval (HIT) (8 x 5-min at 85% VO2peak) running protocol (interspersed by 
3.5 hours) under dietary conditions of 1) high CHO availability (HCHO: CHO ~12 
g.kg-1, EA~ 60 kcal.kg-1 FFM), 2) reduced CHO but high fat availability (LCHF: 
CHO ~3 g.kg-1, EA~ 60 kcal.kg-1 FFM) or 3), reduced CHO and reduced energy 
availability (LCAL: CHO ~3 g.kg-1, EA~ 20 kcal.kg-1 FFM). Muscle glycogen was 
reduced to ~200 mmol.kg-1dw in all trials immediately post PM-HIT (P<0.01) and 
remained lower at 17-h (171, 194 and 316 mmol.kg-1dw) post PM-HIT in LCHF and 
LCAL (P<0.001) compared to HCHO.  Exercise induced comparable p38MAPK 
phosphorylation (P<0.05) immediately-post PM-HIT and similar mRNA expression 
(all P<0.05) of PGC-1α, p53 and CPT1 mRNA in HCHO, LCHF and LCAL. Post-
exercise circulating βCTX was lower in HCHO (P<0.05) compared to LCHF and 
LCAL, whereas exercise-induced increases in IL-6 were larger in LCAL (P<0.05) 
compared to LCHF and HCHO. In conditions where glycogen concentration is 
maintained within 200-350 mmol.kg-1 dw, we conclude post-exercise CHO and 
energy restriction (i.e. <24 hours) does not potentiate cell signalling pathways that 
regulate hallmark adaptations associated with endurance training.  In contrast, 
consuming CHO before, during and after HIT running attenuates bone resorption, 
effects that are independent of energy availability and circulating IL-6. 
Keywords: βCTX, IL-6, caloric restriction, PGC-1α 
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Introduction 
The concept of deliberately promoting reduced carbohydrate (CHO) availability to 
enhance endurance training induced adaptations of skeletal muscle (i.e. the ‘train-low’ 
paradigm) is gaining increased acceptance amongst athletic populations (Bartlett et al. 
2015; Marquet et al. 2016; Burke et al. 2018; Stellingwerff et al. 2019). Over the last 
decade, a multitude of research designs examining the train-low approach (e.g. fasted 
training, twice per day training, sleep low-train low etc.) have consistently 
demonstrated that commencing and/or recovering from a training session with 
reduced CHO availability activates potent cell signalling pathways that regulate many 
of the hallmark muscle adaptations inherent to endurance training (Yeo et al. 2008; 
Bartlett et al. 2013; Psilander et al. 2013). Accordingly, the strategic periodisation of 
reductions in endogenous and/or exogenous CHO availability during 3-10 weeks of 
training increases mitochondrial enzyme activity and protein content (Morton et al. 
2009; Yeo et al. 2008; Van Proeyen et al. 2011), whole body (Yeo et al. 2008) and 
intramuscular (Hulston et al. 2010) lipid metabolism, and may improve exercise 
capacity (Hansen et al. 2005) and performance (Marquet et al. 2016).  
The mechanisms underpinning the apparent enhanced training adaptation associated 
with CHO periodisation is more difficult to interpret in those experimental designs in 
which CHO restriction is simultaneously accompanied by energy restriction. Indeed, 
the performance improvements observed by Marquet et al. (2016) were also 
associated with a 1 kg reduction in fat mass induced by the sleep-low model. 
Notwithstanding reductions in body mass, it is possible that many of the skeletal 
muscle adaptations associated with training-low are mediated by repeated and 
transient periods of energy restriction as opposed to CHO restriction per se. We 
recently observed that the post-exercise mRNA expression of peroxisome 
proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), p53, 
mitochondrial transcription factor A (Tfam) and peroxisome proliferator-activated 
receptor (PPAR) mRNA were increased with similar magnitude and time-course 
when a low CHO and high fat diet was consumed versus an isoenergetic high CHO 
feeding strategy (Hammond et al. 2016). Such data conflict with previous 
observations from our laboratory (Bartlett et al. 2013) where simultaneous post-
exercise CHO and calorie restriction augments the mRNA expression of many of the 
aforementioned genes.  Given the similarities in metabolic adaptation to both CHO 
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and calorie restriction (Meynet and Ricci, 2014), such data raise the question as to 
whether the acute and chronic muscle adaptations observed when training low are 
actually due to transient periods of calorie restriction (as mediated by a reduction in 
CHO intake) as opposed to CHO restriction per se. This point is especially relevant 
given that many endurance athletes present daily with transient periods of both CHO 
and calorie restriction due to multiple training sessions per day as well as longer term 
periods (i.e. weeks) of sub-optimal energy availability (Fudge et al. 2006; Vogt et al. 
2005, Stellingwerff  et al. 2019). 
In addition to the potential effects of muscle glycogen concentration on skeletal 
muscle adaptations (Impey et al. 2018), it is also possible that the acute and transient 
within day fluctuations in both CHO and energy availability (especially in the twice 
per day training model) can exert regulatory effects on other physiological systems, 
many of which are associated with the Relative Energy Deficiency in Sport (RED-S) 
syndrome (Mountjoy et al. 2014).  Therefore, whilst train-low and/or energy 
restriction may be beneficial for certain aspects of training adaptation, the conscious 
or unconscious (as a default of the athlete’s habitual training structure and daily 
pattern of feeding) manipulation of CHO and energy availability may have negative 
implications for indicators of the RED-S syndrome. As such, the acute regulation of 
bone turnover (i.e. alterations in resorption and formation, Sale et al., 2015), immune 
function (Nieman, 2007), endocrine function (Loucks et al. 1998; Hagmar et al. 2013) 
and appetite regulation (Considine et al. 1996) may be negatively impacted, the result 
of which could increase injury risk and impair athletic performance if performed 
chronically.   
With this in mind, the aim of the present study was to examine the effects of post-
exercise CHO and caloric restriction on the modulation of skeletal muscle cell 
signalling pathways associated with the regulation of mitochondrial biogenesis and 
lipid metabolism as well as indicators of bone metabolism. We employed a repeated 
measures crossover design whereby male runners completed a twice per day exercise 
model consisting of a morning and afternoon high-intensity interval training session. 
Runners completed the training sessions under three dietary conditions comprising 
high CHO availability (HCHO) in the recovery period after both training sessions (i.e. 
usually considered as best practice recovery nutrition), reduced CHO but high fat 
availability (LCHF) or finally, reduced CHO and reduced energy intake (LCAL).  In 
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this way, our experimental design allowed us to evaluate the effects of post-exercise 
CHO restriction in modulating adaptive responses of muscle and bone in conditions 
of both sufficient or reduced energy availability. We hypothesised that post-exercise 
CHO restriction only modulates cell signalling, gene expression and bone metabolism 
when energy intake is simultaneously reduced. 
 
Methods 
Ethical Approval: All participants gave written informed consent prior to 
participation after all experimental procedures and potential risks had been fully 
explained. The study was approved by the ethics committee of Liverpool John 
Moores University (Ethics No: 15 SPS 60) and conformed to the standards set by the 
latest revision of the Declaration of Helsinki (except for registration in a database). 
Participants: Nine male runners volunteered to participate in the study (mean ± SD: 
age, 21 ± 1.9 years; body mass, 71.4 ± 7 kg; height, 1.78 ± 0.04 m; VO2peak, 57 ± 5.1 
ml·kg-1·min-1). None of the participants had any history of musculoskeletal or 
neurological disease, nor were they under any pharmacological treatment over the 
course of the testing period. Participants were instructed to refrain from any strenuous 
physical activity, alcohol and caffeine consumption in the 24 h prior to each 
experimental trial.  On the basis of previous studies demonstrating that CHO 
availability can regulate skeletal muscle p38MAPK signalling (Cochran et al. 2012; 
mean paired differences of -2 fold change between conditions and SD of differences 
of 1.5-fold), post-exercise PGC-1α mRNA expression (Pilegaard et al. 2005; mean 
paired differences of -3 fold change between conditions and SD of differences of 2-
fold) and post-exercise AUC for circulating plasma CTx concentrations (Sale et al. 
2015; mean paired differences of 5% changes between conditions and SD of 
differences of 3%), it was estimated that sample sizes of 7-9 were deemed appropriate 
to detect statistical significance at an alpha level of 0.05 and 80% power.  Sample size 
estimation calculations were undertaken using Minitab software, version 19.1. 
Design: In a repeated measures, randomised, cross-over design separated by 7 days, 
participants completed a twice per day exercise model under three different dietary 
conditions, consisting of either high CHO availability (HCHO) in the recovery period 
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after both training sessions (i.e. best practice nutrition), reduced CHO but high fat 
availability (LCHF), or reduced CHO but reduced energy availability (LCAL). The 
twice per day exercise model comprised a morning (9-10 am) high-intensity interval 
(AM-HIT) training session (8 x 5-min at 85% VO2peak) followed by an afternoon 
(130-230 pm) training session consisting of the same high-intensity interval exercise 
bout (PM-HIT).  To promote training compliance during the AM-HIT protocol in all 
three trials, participants adhered to a standardised high CHO breakfast prior to this 
session. However, during the 3.5 h recovery between the HIT sessions and in the 
recovery period upon completion of the PM-HIT exercise protocol until the 
subsequent morning, participants adhered to either the HCHO, LCHF, or LCAL 
feeding protocol. Muscle biopsies were obtained from the m. vastus lateralis muscle 
immediately pre AM-HIT, immediately post PM-HIT and at 3 h and 17 h post PM-
HIT. An overview of the experimental design and nutritional protocols are shown in 
Figure 1.  
Preliminary testing: At 7 days prior to the first main experimental trial, participants 
performed a combined running economy and maximal incremental running test to 
volitional fatigue on a motorised treadmill (h/p/Cosmos, Nussdorf-Traunstein, 
Germany). Both peak oxygen uptake and individual running speeds for the 
subsequent experimental trials were determined. Following a 10-minute warm up at a 
self-selected treadmill speed, the running economy test commenced, beginning with a 
3-min stage at a treadmill speed of 10 km.h-1. Running speed was then increased by 1 
km.h-1 every 3-min thereafter until participants reached >90% of their age predicted 
maximal heart rate. Participants were then given a 5-min rest period before 
commencing the maximal incremental test. This test began with a 2-min stage at a 
treadmill speed 2 km.h-1 slower than the final speed of the running economy test. 
Running speed was then increased by 2 km.h-1 every 2-min until a speed of 16 km.h-1 
was reached, after which the treadmill inclined by 2% every 2-min until volitional 
exhaustion. VO2peak was defined as the highest VO2 value obtained during any 10-s 
period and was stated as being achieved by two of the following criteria: 1) heart rate 
was within 10 beats.min-1 (b.min-1) of age-predicted maximum, 2) respiratory 
exchange ratio > 1.1, and 3) plateau of oxygen consumption despite increased 
workload.  These measurements were recorded via breath-by-breath gas analysis 
obtained continuously throughout both tests using a CPX Ultima series online gas 
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analysis system (Medgraphics, Minnesota, US), with heart rate (Polar, Kempele, 
Finland) also recorded continuously during exercise.   
 
 
Experimental protocols: 
AM HIT protocol: In the 24-h preceding each main experimental trial, participants 
consumed a standardised high CHO diet in accordance with typical nutritional 
recommendations (Thomas et al. 2016) for endurance athletes (8 g.kg-1 CHO, 2 g.kg-1 
protein, and 1 g.kg-1 fat) performing between 1-3 hours of exercise per day.  On the 
morning of each experimental trial, participants reported to the laboratory between 7 
and 7.15 am where a venous blood sample was collected from an antecubital vein in 
the anterior crease of the forearm. Participants were then given a standardised high-
CHO breakfast (2 g.kg-1 CHO, 0.3 g.kg-1 protein, and 0.1 g.kg-1 fat; comprising 
breakfast cereal, milk, orange juice, bread and jam), and at 2-h post-prandial, a 
muscle biopsy sample was obtained from the vastus lateralis muscle.  Participants 
were then fitted with a heart rate monitor and nude body mass (SECA, Hamburg, 
Germany) was recorded before commencing the first high intensity interval running 
(AM-HIT) protocol which lasted ~1-h. The HIT protocol consisted of 8 x 5-min bouts 
running at a velocity corresponding to 85% VO2peak interspersed with 1-min of 
recovery at walking pace.  The intermittent protocol started and finished with a 10-
min warm up and cool down at a velocity corresponding to 50% VO2peak, and a further 
venous blood sample was obtained immediately upon completion of the protocol. 
Water was consumed ad libitum throughout the duration of exercise with the pattern 
of intake recorded and replicated for the subsequent experimental trials. Heart rate 
was measured continuously during exercise (Polar, Kempele, Finland) and ratings of 
perceived exertion (RPE, Borg, 1973) were obtained upon completion of each HIT 
bout.  In order to determine substrate utilisation and energy expenditure during 
exercise (Jeukendrup and Wallis, 2005), expired gas was collected via a mouthpiece 
connected to an online gas analysis system (CPX Ultima, Medgraphics, Minnesota, 
US) for the final 2-mins of each 5-min interval.   
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PM HIT protocol:  During the 3.5 h recovery period between the AM-HIT and PM-
HIT protocols, participants consumed either the HCHO (3.5 g.kg-1 CHO, 0.8 g.kg-1 
Protein, 0.2 g.kg-1 Fat), LCHF (0 g.kg-1 CHO, 0.8 g.kg-1 Protein, 1.2 g.kg-1 Fat), or 
LCAL (0 g.kg-1 CHO, 0.8 g.kg-1 Protein, 0.1 g.kg-1 Fat) feeding protocols (the pattern 
and frequency of feeding is shown in Figure 1).  Following the recovery period, 
another venous blood sample was obtained immediately prior to commencing the 
afternoon HIT exercise protocol. After a 10-min warm up at a velocity corresponding 
to 50% VO2peak, participants subsequently commenced the PM HIT protocol.  During 
exercise, participants also consumed 60 g.h-1 of CHO (SiS GO Isotonic Gels, Science 
in Sport, Blackburn, UK) in HCHO whereas no energy was consumed in the LCHF or 
LCAL trials. Water was consumed ad libitum throughout the duration of exercise with 
the pattern of intake recorded and replicated for the subsequent experimental trial. 
Expired gases were collected for the last 2-mins of each 5-min interval throughout the 
exercise trial (CPX Ultima, Medgraphics, Minnesota, US) and substrate utilisation 
and energy expenditure was determined according to the method of Jeukendrup and 
Wallis (2005). Heart rate was measured continuously during exercise (Polar, 
Kempele, Finland) and RPE (Borg, 1973) were obtained at the end of each HIT bout. 
Upon completion of the PM-HIT protocol until sleep, participants consumed either 
the HCHO (6.4 g.kg-1 CHO, 1.3 g.kg-1 Protein, 0.3 g.kg-1 Fat), LCHF (0.8 g.kg-1 
CHO, 1.3 g.kg-1 Protein, 2.3 g.kg-1 Fat), or LCAL (0.8 g.kg-1 CHO, 1.3 g.kg-1 Protein, 
0.1 g.kg-1 Fat) feeding protocols where the pattern and frequency of feeding is shown 
in Figure 1. Vastus lateralis muscle biopsies and venous blood samples were also 
collected immediately post- and at 3 h and 17 h post completion (i.e. 8 am and in a 
fasted state) of the PM-HIT exercise protocol.  The total energy and estimated 
calcium intake across the whole trial period in HCHO was: ~12.6 g.kg-1 CHO, ~2.3 
g.kg-1 Protein, ~0.6 g.kg-1 Fat, 1051 mg calcium, in LCHF was: ~3 g.kg-1 CHO, ~2.3 
g.kg-1 Protein, ~3 g.kg-1 Fat , 1780 mg calcium (where both trials were matched for 
total energy intake), and in LCAL was ~3 g.kg-1 CHO, ~2.3 g.kg-1 Protein, ~0.4 g.kg-1 
Fat, 865 mg calcium.  Typical energy sources in the HCHO trial consisted of rice, 
bananas, sports drinks (e.g. Lucozade Original, UK; GO Energy and REGO, Science 
in Sport, UK), sports gels (GO Isotonic Energy Gels, Science in Sport, UK) and 
confectionary products (e.g. Jaffa Cakes, McVities, UK) whereas increased dietary fat 
intake in the LCHF trial was reflective of increased intake of oily fish, avocado, 
butter, coconut oil, walnuts and cheese. In the LCAL trial, CHO intakes were limited 
 10 
to smaller absolute portions of rice and none of the aforementioned sources of dietary 
fat were consumed. 
Energy Availability: Energy availability was estimated for each experimental trial as 
calculated from: energy intake minus energy expenditure during AM-HIT and PM-
HIT exercise / fat free mass (FFM) (Mountjoy et al., 2014). Whilst FFM was not 
directly measured, we based estimates of FFM on the assumption that all participants 
were ~15% body fat (as based on unpublished data from our laboratory examining 
male participants of similar body mass, training history and maximal oxygen uptake, 
Impey et al.). The total energy expenditure from both AM-HIT and PM-HIT in 
HCHO was 1474 ± 107 kcal, in LCHF was 1429 ± 142 kcal and in LCAL was 1455 ± 
190 kcal. Estimated energy availability across the whole trial period in HCHO was 58 
± 5.3 kcal.kg-1 FFM, in LCHF was 59 ± 6.4 kcal.kg-1 FFM, and in LCAL was 20 ± 4.1 
kcal.kg-1 FFM.  
Blood sampling and analysis: Venous blood samples were collected into vacutainers 
containing EDTA or lithium heparin and stored on ice until centrifugation at 1500 xg 
for 15-mins at 4ºC.  Following centrifugation, aliquots of plasma were stored in a 
freezer at -80ºC for subsequent analysis.  Samples were later analysed for plasma 
glucose, lactate, non-esterified fatty acids (NEFA), glycerol, and β-hydroxybutyrate 
using commercially available enzymatic spectrophotometric assays (RX Daytona 
Analyser, Randox, Co. Antrim, UK) as per the manufacturers’ instructions. Samples 
were also analysed using commercially available solid phase enzyme-linked 
immunosorbent assays (ELISA) for insulin (DIAsource, Belguim), leptin (R&D 
systems, Minnesota, USA) ghrelin (Invitrogen, Thermo Fisher Scientific, UK) and 
adiponectin (Abcam, Cambridge, UK) as per the manufacturers instructions.  Plasma 
βCTX and P1NP were measured by ECLIA on a fully automated COBAS e601 
system (Roche Diagnostics, Mannheim, Germany). These markers were selected for 
use as they are the preferred markers of use as reference analytes for bone turnover 
markers in clinical studies (Vasikaran et al., 2011). The inter-assay CV for βCTX was 
≤3% between 0.2 – 1.5 μg.L-1, with a sensitivity of 0.01 μg.L-1, and the inter-assay 
CV for P1NP was ≤3% between 20 – 600 μg.L-1, with a sensitivity of 8 μg.L-1.  The 
assays used a sandwich test principle involving two incubations. Flow cytometric 
detection of IL-6 was performed using a dual-laser FACSCalibur flow cytometer (BD 
biosciences, USA) calibrated for 2-colour analysis.  Cytokine concentrations were 
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measured using a cytometric bead array (CBA, BD Biosciences, San Diego, USA) 
according to the manufacturers instructions. Bead populations with distinct 
fluorescence intensities coated with phycoerythrin (PE)-conjugated capture antibodies 
specific for IL-6 were used. Following acquisition of sample data using the flow 
cytometer, the sample results were generated in graphical and tabular format using the 
BDA CBA Analysis Software.  
 
Muscle biopsies: Muscle biopsy samples (~60 mg) were obtained from the lateral 
portion of the vastus lateralis muscle using a Bard Monopty Disposable Core Biopsy 
Instrument 12 gauge x 10 cm length, (Bard Biopsy Systems, Tempe, AZ, USA).  
Consecutive biopsies were taken from alternate legs. Samples collected from the same 
limb were obtained from separate incision sites 2-3 cm apart under local anaesthesia 
(0.5% Marcaine) and immediately frozen in liquid nitrogen and stored at -80ºC for 
later analysis.     
Analysis of muscle glycogen: Muscle glycogen concentration was determined 
according to the methods described by Van Loon et al (2000). Approximately 3-5 mg 
of freeze-dried muscle was powdered and all visible blood and connective tissue 
removed.  The freeze-dried sample was then hydrolysed by incubation in 500 µl of 
1M HCl for 3 hours at 100◦C.  After cooling to room temperature for ~20-min, 
samples were neutralized by the addition of 250µl 0.12 mol.L-1 Tris/2.1 mol.L-1 KOH 
saturated with KCl.  Following centrifugation at 1500 RCF for 10-mins at 4ºC, 200 µl 
of the supernatant was analysed in duplicate for glucose concentration according to 
the hexokinase method using a commercially available kit (GLUC-HK, Randox 
Laboratories, Antrim, UK). Glycogen concentration is expressed as mmol.kg-1 dry 
weight. 
Analysis of phosphorylated p38 MAPK T180/Y182 phosphorylation: Flow cytometric 
detection of phosphoproteins was performed using a dual-laser BD C6 accuri flow 
cytometer (BD biosciences, USA).  Phospho-p38 concentrations were measured using 
a cytometric bead array (CBA, BD Biosciences, San Diego, USA) according to the 
manufacturers instructions. Bead populations with distinct fluorescence intensities 
coated with phycoerythrin (PE)-conjugated capture antibodies specific for phospho-
p38 were used. Following acquisition of sample data using the flow cytometer, the 
sample results were generated in graphical and tabular format using the BDA CBA 
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Analysis Software (Hungary Software Ltd., for BD Biosciences, San Jose, CA, USA) 
where median values were used. Briefly, muscle samples (~20 mg) were 
homogenised in 200µl of denaturation buffer (BD biosciences, UK) in beaded tubes 
(Roche, UK) using a Roche MagnaLyser instrument.  Samples were homogenized for 
45 seconds at 6000 rpm x 3 with 5-mins on ice between runs. Protein concentrations 
were determined using a BCA protein assay, and samples added to the assay diluent 
provided (100µg/sample).  Standards were prepared by serial dilution of a stock 
protein in the BD CBA Cell Signalling Flex Set. All samples and standards were 
incubated with the capture beads conjugated to the p38MAPK T180/Y182 antibody for 3-
h then with the Phycoerythrin (PE) detection reagent for 1-h. Samples were then 
washed using the wash buffer provided and centrifuged at 300g for 5-mins before 
supernatant was removed and 300µl of wash buffer was added for re-suspension of 
the capture beads. All samples were analysed on the flow cytometer with 300 events 
captured per sample.  
 
RNA isolation and analysis: Muscle biopsy samples (~20 mg) were homogenized in 
1ml TRIzol reagent (Thermo Fisher Scientific, UK) in beaded tubes (Roche, UK) 
using a Roche MagnaLyser instrument.  Samples were homogenized for 45 seconds at 
6000 rpm x 3 with 5-mins on ice between runs. Total RNA was then isolated 
according to manufacturer’s guidelines. High quality RNA was assessed by UV 
spectroscopy at ODs of 260 and 280 nm (mean±SD was 1.99±0.05 for 260/280 nm 
ratios) using a Nanodrop 3000 (Fisher, Rosklide, Denmark). 70 ng RNA was then 
used for each PCR reaction.  Samples were analysed in duplicate. 
Primers: Identification of primer sequences was enabled by Gene 
(NCBI, http://www.ncbi.nlm.nih.gov.gene) and primers designed using Primer-
BLAST (NCBI, http://www.ncbi.nlm.nih.gov/tools/primer-blast). Specificity was 
ensured using sequence homology searches so the primers only matched the 
experimental gene with no unintended targets identified for primer sequences.  In 
order to prevent amplification of gDNA, primers were ideally designed to yield 
products spanning exon-exon boundaries. 3 or more GC bases in the last 5 bases at 
the 3 end, and secondary structure interactions (hairpins, self-dimer and cross dimer) 
within the primers were avoided so there would be no non-specific amplification. All 
primers were between 16 and 25bp, and amplified a product between 141 – 244bp.  
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All primers were purchased from Sigma (Suffolk, UK) and sequences for each gene 
are shown in Table 1 for: peroxisome proliferator-activated γ receptor coactivator 
(PGC-1), tumour suppressor protein (p53), mitochondrial transcription factor A 
(Tfam), pyruvate dehydrogenase kinase isozyme 4 (PDK4), carnitine 
palmitoyltransferase (CPT1), fatty acid translocase (FAT/CD36), Sirtuin 1 (SIRT1), 
Parkin, and GAPDH. 
Reverse transcriptase quantitative Real-Time Polymerase Chain Reaction (rt-qRT-
PCR): rt-qRT-PCR amplifications were performed using a 
QuantiFastTM SYBR® Green RT-PCR one step kit on a Rotogene 3000Q (Qiagen, 
Crawley, UK) supported by Rotogene software (Hercules, CA, USA). The following 
rt-qTR-PCR cycling parameters were used: hold 50°C for 10 min (reverse 
transcription/cDNA synthesis), initial denaturation and transcriptase inactivation at 
95°C for 5 min, followed by PCR steps: 40 cycles of denaturation at 95°C for 10s, 
and annealing/extension at 60°C for 30s. Upon completion, dissociation/melting 
curve analysis were performed to reveal and exclude non-specific amplification or 
primer-dimer issues (all melt analysis presented single reproducible peaks for each 
target gene suggesting amplification of a single product). Changes in mRNA content 
were calculated using the comparative Ct (ΔΔCt) equation (Schmittgen and Livak, 
2008) where relative mRNA expression was calculated as 2-ΔΔct and where represents 
the threshold cycle. GAPDH was used as a reference gene and did not change 
significantly between groups or time points studied (Ct = 24.2±1), therefore a pooled 
reference gene Ct was used in the relative mRNA expression equation above.  
Furthermore, to enable calculation of mRNA expression values immediately post and 
3-h post exercise, the calibrator condition in the delta delta Ct equation was assigned 
to the pre-exercise condition.     
Statistical analysis: All data were analysed using Statistical Package for the Social 
Scientist (SPSS version 21, IBM, USA). Metabolic responses (i.e. blood metabolites, 
muscle glycogen, kinase activity, mRNA data), physiological and perceptual 
responses (i.e. HR, RPE, and oxidation rates) were analysed using a two-way 
repeated-measures general linear model, where the within factors were time and 
condition. Post hoc LSD tests were used where significant main effects and 
interactions were observed in order to locate specific differences between time points 
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and conditions. All data in text, figures and tables are presented as mean ± SD, with P 
values ≤0.05 indicating statistical significance.  
 
Results 
Physiological responses and substrate utilisation during exercise. Comparisons of 
subject’s heart rate, RPE and substrate oxidation during both the AM-HIT and PM-
HIT protocols are displayed in Figure 2. Heart rate, RPE and lipid oxidation (all 
P<0.001) progressively increased during both AM-HIT and PM-HIT exercise whereas 
CHO oxidation progressively decreased (P<0.001) during both exercise protocols (see 
Figure 2). In accordance with identical pre-exercise feeding in all trials prior to AM-
HIT, no significant differences were apparent in any of the aforementioned variables 
between HCHO, LCHF, and LCAL (all P>0.05). In contrast, CHO oxidation was 
significantly greater during PM-HIT in HCHO compared to LCHF (P=0.001) and 
LCAL (P=0.004) whereas lipid oxidation was significantly greater during LCHF 
(P=0.014) and LCAL (P=0.011) compared to HCHO. No differences were observed 
in either CHO (P=0.595) or lipid (P=0.403) oxidation between LCAL and LCHF 
during PM HIT.  
 
Plasma metabolite responses. Plasma glucose, lactate, NEFA, glycerol and β-
hydroxybutyrate all displayed significant changes (all P<0.001) over the sampling 
period (Figure 3). However, in accordance with the provision of CHO in the HCHO 
trial, plasma glucose was significantly higher compared with LCHF (P<0.001) and 
LCAL (P=0.003) whereas restricting CHO and energy intake post-exercise induced 
significantly greater plasma NEFA and β-OHB in LCHF (P=0.001 and 0.001) and 
LCAL (P=0.007 and 0.001) compared with the HCHO trial. There was a tendency for 
higher circulating NEFA in LCHF compared with LCAL (P=0.06) and β-OHB was 
also different (P=0.024) between LCHF and LCAL. Plasma glycerol significantly 
increased in response to both AM-HIT (P=0.001) and PM-HIT (P<0.001), although 
this response was not different between trials (P=0.362). Similarly, plasma lactate 
concentrations were significantly increased in response to AM-HIT (P<0.001) and 
PM-HIT (P=0.004), with no differences between feeding conditions (P=0.383).  
Consistent with CHO feeding before and after PM-HIT, plasma insulin concentration 
was significantly higher (all P<0.01) immediately post, 3-h post, and 17-h post-
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exercise in HCHO compared with LCHF and LCAL (Figure 3). Additionally, insulin 
concentration significantly changed over time (P<0.001) such that significant 
differences from Pre- AM HIT were evident immediately post (P<0.001) and 3-h after 
completion of the PM HIT session (P=0.024). 
 
Muscle glycogen.  Exercise significantly decreased (P<0.01) muscle glycogen 
immediately post-PM HIT, though no differences were apparent between HCHO, 
LCHF, and LCAL at this time-point (see Figure 4). However, in accordance with the 
provision of CHO after the PM HIT exercise protocol in HCHO, muscle glycogen re-
synthesis was observed such that glycogen concentration was higher in HCHO 
compared with both LCHF (P=0.028) and LCAL (P=0.002) at 3-h and 17-h post 
exercise.   
p38MAPKT180/Y182 Phosphorylation. Exercise induced significant increases in 
p38MAPK phosphorylation immediately post PM-HIT (P=0.037) though no 
differences (P=0.755) were observed between trials (Figure 5). At 17-h post PM-HIT, 
p38MAPK phosphorylation had returned to basal levels in all three experimental 
trials.  
Gene expression. Exercise increased the expression of PGC-1α (P<0.001), p53 
(P=0.01), and CPT1 mRNA (P<0.001) although there were no differences (all 
P>0.05) between trials (Figure 6).  In contrast, the exercise-induced increase 
(P=0.001) in PDK4 mRNA was greater in LCHF (P=0.002) and LCAL (P=0.034) 
versus HCHO at 3-h post exercise (Figure 6). Similarly, mRNA expression of SIRT1 
was significantly greater in LCAL compared to HCHO (P=0.013) at 17 h -post 
exercise (Figure 6). In contrast, neither exercise nor dietary condition significantly 
affected the mRNA expression of CD36 (P=0.901 and P=0.206, respectively), Parkin 
(P=0.25 and 0.74, respectively) or Tfam (P= 0.17 and P=0.38 respectively). 
Bone metabolism. Exercise significantly increased P1NP (P<0.01) following both 
AM-HIT (P=0.011) and PM-HIT (P=0.005) with concentrations subsequently 
decreasing at 3-h (P=0.041) and 17-h post-exercise (P=0.002) (Figure 7). No 
differences were apparent between trials (P=0.633). Exercise significantly reduced 
βCTX concentration following AM-HIT (P<0.001) whilst PM-HIT significantly 
increased βCTX (P<0.001) (Figure 6).  βCTX concentration was significantly lower 
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immediately pre-, post- and 3-h post-PM HIT in HCHO compared to LCHF 
(P=0.032) and LCAL (P=0.035).   No differences were apparent in the response of 
βCTX between the LCHF and LCAL trials (P=0.178). 
Appetite hormones. Whilst exercise did not affect circulating leptin concentration 
(P=0.72), leptin was significantly lower (P=0.041) in LCAL compared to HCHO in 
the post exercise sampling period (Figure 7). There was a tendency for differences in 
leptin concentration between HCHO and LCHF (P=0.057) though no differences were 
apparent between LCAL and LCHF (P=0.27). Exercise significantly reduced ghrelin 
concentration to comparable levels in all three trials following both AM-HIT (P = 
0.001) and PM-HIT (P = 0.025), with no significant differences between conditions 
(P=0.408) (Figure 7). Ghrelin concentration returned to baseline levels at 17-h post 
PM-HIT in all conditions (P = 0.392).  Neither exercise (P=0.524) nor dietary 
condition (P=0.156) significantly affected adiponectin concentration throughout the 
sampling period (Figure 7). 
Interleukin-6 (IL-6) responses.  Exercise significantly increased IL-6 concentration 
immediately post PM-HIT (P=0.016) and at 3-h post PM-HIT (P=0.009), the 
magnitude of which was higher in LCAL compared to LCHF (P=0.021) and HCHO 
(P=0.016) (Figure 7).  There were no differences in post-exercise elevations in IL-6 
concentration between LCHF and HCHO (P=0.145). Plasma IL-6 concentration 
returned to baseline levels at 17-h post-PM-HIT in all three experimental trials.   
 
Discussion 
In contrast to our hypothesis, we provide novel data by demonstrating that 
simultaneous post-exercise CHO and energy restriction did not augment acute cell 
signalling (i.e. p38MAPK-PGC-1α pathway) that is associated with mitochondrial 
biogenesis and lipid metabolism, as compared with conditions of high energy 
availability. We also report for the first time that consuming CHO before, during and 
after HIT running attenuates circulating βCTX concentrations in the hours after 
exercise, effects that are independent of energy availability. When taken together, our 
data suggest that in recovery conditions where muscle glycogen concentration 
remains within the range of 200-350 mmol.kg-1 dw, acute post-exercise CHO and 
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energy restriction (i.e. <24 hours) does not potentiate the activation of key cell 
signalling responses that are associated with the regulation of hallmark adaptations to 
endurance training.  Nonetheless, the acute within day fluctuation in CHO availability 
that is inherent to twice per day training protocols modulates bone resorption, though 
the chronic implications of these acute alterations remain to be determined.  
Similar to the original train-low investigations (Hansen et al. 2005; Yeo et al. 2008; 
Morton et al. 2009), we employed a twice per day exercise protocol (considered 
representative of real-world practices often adopted by elite endurance athletes), 
whereby multiple training sessions are completed on the same day with limited 
recovery time between sessions (Fudge et al. 2006). Having adhered to a high CHO 
diet during the day prior to all three experimental trials and after consuming a 
standardised high CHO breakfast, we observed no differences in cardiovascular 
strain, RPE, substrate availability or substrate oxidation during the AM-HIT session. 
In accordance with the provision of CHO intake between training sessions during the 
HCHO trial, we subsequently observed higher rates of CHO oxidation during PM-
HIT when compared with both the LCHF and LCAL trials, likely reflective of the 
higher pre-exercise muscle glycogen availability and the provision of exogenous 
CHO during exercise (Bartlett et al. 2013). Nonetheless, despite higher circulating 
NEFA levels in LCHF compared with the LCAL trial, we observed comparable lipid 
oxidation rates between the LHCF and LCAL trials, both of which were significantly 
higher than HCHO. These data are in agreement with classical studies demonstrating 
that in high-intensity exercise conditions, elevations in circulating free fatty acid 
(FFA) availability (i.e. >1 mmol.L-1) does not readily translate to increased rates of 
whole body lipid oxidation (Romijn et al. 1995), owing to limitations in FFA uptake 
across the mitochondrial membrane during conditions of high glycolytic flux 
(Sidossis et al. 1997).   
It is, of course, difficult to draw accurate conclusions on rates of lipolysis based on 
measurements of circulating glycerol and NEFA per se. Nonetheless, on the basis of 
statistical differences in plasma NEFA concentrations between trials immediately 
post- PM-HIT and consistent with the well-documented effects of CHO feeding 
(Horowitz et al. 1997), it is assumed that lipolysis was suppressed in the HCHO trial 
when compared with both the LCAL and LCHF trials.  The fact that plasma glycerol 
did also not display statistical differences between trials may be potentially reflective 
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of greater glycerol uptake by the liver in both the LCAL and LCHF trials in order to 
provide a gluconeogenic substrate to maintain plasma glucose concentration (Ahlborg 
et al. 1974; Jensen et al. 2001). Interestingly, the return of β-OHB towards basal 
levels at +17 h in the LCHF trial is consistent with our previous publication utilising 
an almost identical dietary and exercise protocol (Hammond et al. 2016), whilst the 
progressive increase in β-OHB at this time-point in the LCAL trial is consistent with 
the well-documented effects of post-exercise calorie restriction on ketosis (Impey et 
al. 2016).  In relation to the former, it is possible that that the provision of dietary fat 
intake in the evening meal (i.e. 9 pm) may result in an increase in liver uptake of 
NEFA in an attempt to preferentially stimulate gluconeogenesis (Chen et al. 1999), 
the result of which may actually suppress ketogenesis. We acknowledge, however, 
that further studies are now required to directly test this hypothesis. 
In relation to upstream skeletal muscle cell signalling, the phosphorylation of 
p38MAPKT180/Y182 immediately post PM-HIT was comparable between all trials. 
Despite the potentially increased pre-exercise muscle glycogen availability and 
utilisation during HCHO (owing to the consumption of CHO between sessions), such 
a comparable signalling response is not unexpected given that the absolute post-
exercise glycogen concentration (i.e. approximately 200 mmol.kg-1 dw) was similar 
between trials. In accordance with comparable upstream signalling (Wright et al. 
2007), we subsequently observed similar magnitudes of mRNA expression of PGC-
1α, p53, and CPT1 in the first 3 hours of recovery from PM-HIT.  Furthermore, 
despite the sustained CHO and energy restriction for the subsequent 12-hour recovery 
period, we observed that neither energy nor CHO availability had no further 
modulatory effect on mRNA expression (with the exception of both PDK4 and 
SIRT1). Such data contrast with those of Pilegaard et al. (2005) who observed that 8 
hours of post-exercise CHO restriction (0.5 g.kg-1 of CHO) enhanced PGC-1α, CPT1 
and CD36 mRNA when compared with recovery conditions where 5 g.kg-1 of CHO 
was consumed in the initial 8 h post-exercise period. Such discrepancies between 
studies may be explained by the absolute glycogen concentrations achieved by the 
chosen feeding protocol. Indeed, whereas we achieved absolute muscle glycogen 
concentrations of approximately 350 (in the HCHO trial) versus 200 mmol.kg-1 dw (in 
the LCHF and LCAL trials) at 17 hours post-completion of the PM-HIT session, the 
feeding protocol adopted by Pilegaard et al. (2005) achieved glycogen concentrations 
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of 550 versus 350 mmol.kg-1 dw in their conditions of high and low CHO availability, 
respectively. When considered this way, our data may lend further support for the 
glycogen threshold hypothesis (Impey et al. 2018) surmising that the acute cell 
signalling (Gejl et al. 2017) and chronic training adaptations (Hansen et al. 2005; 
Morton et al. 2009; Yeo et al. 2008) associated with “train-low” protocols typically 
only present when absolute glycogen concentration is depleted to <300 mmol.kg-1 dw. 
As such, it is possible that the acute manipulation of both CHO and energy 
availability in relation to the exercise protocols and participant training status studied 
here were likely not sufficient to elicit post-exercise metabolic conditions that could 
be considered indicative of “true” train-low conditions. Indeed, in a previous study 
from our laboratory where we utilised a sleep low manipulation of muscle glycogen 
(as achieved via evening glycogen depleting exercise followed by overnight CHO and 
energy restriction), we observed that differences in muscle glycogen availability of 
400 versus 100 mmol.kg-1 dw induced marked differences in expression of PGC-1α, 
CPT1 and Tfam mRNA (Bartlett et al. 2013). Future studies should therefore adopt 
experimental designs and feeding protocols that more readily achieve distinct 
differences in muscle glycogen availability. 
Exercise training is largely considered anabolic to bone, as mediated by the 
mechanical signalling pathways inherent to the pattern of loading (Ozcivici et al. 
2010; Thompson et al. 2012; Pagnotti et al. 2019).  Nonetheless, the extent of 
increased bone formation and decreased bone resorption that may occur in response to 
exercise training (Fujimura et al. 1997) is, of course, dependent on genetics, age, 
exercise modality (i.e. loading pattern) and energy availability.  In this way, bone 
mineral density (BMD) may differ markedly amongst elite athletic populations such 
as soccer players, swimmers, cyclists, runners and jockeys (Olmedillas et al. 2012; 
Gomez-Bruton et al. 2013; Fredericson et al. 2007; Scofield and Hecht, 2012; Wilson 
et al. 2018).  In relation to the acute markers of bone metabolism studied here, we 
observed comparable responses of P1NP and βCTX following the AM-HIT training 
session, likely due to the identical CHO intake in both the 24 h control diet and the 
pre-training breakfast.  In contrast, subsequent ingestion of CHO in the 3-h recovery 
period prior to PM-HIT caused a greater suppression in βCTX compared with those 
conditions where energy was restricted (LCAL) or matched by consuming the 
isocaloric high fat diet (LCHF). Similarly, when CHO was ingested during PM-HIT 
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and in the subsequent 3-h recovery period, there was a greater suppression in βCTX 
immediately post- and 3-h post-exercise.  The apparent suppression of βCTX with 
CHO feeding agrees with previously reported observations, albeit under resting 
conditions, where a reduction in βCTX in response to an oral glucose tolerance test 
has been reported (Bjarnason et al. 2002; Bergmann et al. 2019).  The finding that 
CHO availability attenuates post-exercise circulating βCTX is also similar to previous 
researchers who reported that consuming an 8% CHO solution before and during a 
prolonged bout of running (120-mins at 70% of VO2max) induced a greater reduction 
in βCTX compared with a placebo solution (Sale et al. 2015). Furthermore, de Sousa 
et al. (2014) also observed a reduction in the bone resorption response (as determined 
by βCTX) to an acute exercise bout following an 8 day ‘overload training program’ in 
individuals fed a higher CHO diet during training. The CHO group consumed an 
additional 1 g of maltodextrin·kg-1 body mass per hour of running during the 8 days 
of training compared with the control group. When specifically examining the effects 
of feeding during the post-exercise recovery period, Townsend et al. (2017) also 
demonstrated that consuming a mixed CHO and protein recovery drink immediately 
following an exhaustive run significantly suppressed βCTX when compared to a 
placebo solution.  When taken together, the present data therefore confirms but 
extends the previous observations given that we observed no differences in βCTX 
between the LCHF and LCAL trials, thus demonstrating that it is the energy from 
CHO, rather than overall energy availability, that is important in attenuating the bone 
resorption response to an acute training session.  In contrast to βCTX, however, we 
observed no affect of dietary condition on markers of bone formation (i.e. P1NP).  
Such data contrast with those of Sale et al. (2015) who reported that CHO feeding 
before and during exercise also reduces post-exercise P1NP concentrations. Our data 
therefore suggest that the influence of CHO availability in the current study was 
confined (at least within the study timeframe) to bone resorption.  We acknowledge, 
however, the limitation of solely measuring βCTX and P1NP and suggest that future 
studies may benefit from measurement of additional markers of bone formation and 
resorption such as that associated with Wnt-β-catenin signalling and the 
RANKL/RANK/OPG pathway (Ozcivici et al. 2010).  The assessment of renal 
function may also prove beneficial given the possibility that changes in renal function 
as a result of high-intensity exercise and energy restriction may influence the 
excretion rate of βCTX and hence, its relative concentration. 
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The potential mechanisms for acute suppression of bone resorption by CHO feeding 
are still not fully understood, although it has been suggested that the enteric hormones 
might play a part in mediating the effects of glucose on bone metabolism (Bjarnson et 
al., 2002; Henriksen et al., 2003).  Indeed, when enteric hormone secretion was 
limited by somatostatin administration, the reduction in bone resorption following 
oral glucose ingestion was negated (Clowes et al., 2003). Accordingly, Bergmann et 
al. (2019) have also recently demonstrated that the gut derived incretin hormones, 
glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 
(GLP-1), could be involved in regulation of bone resorption during glucose 
administration, as evidenced by a suppression in βCTX in response to glucose 
infusion when both hormones are also simultaneously infused.   Additionally, specific 
regulatory effects of insulin (Clowes et al, 2002), leptin (Thomas & Burguera, 2002; 
Holloway et al. 2002) and/or IL-6 (Sale et al. 2015) signalling have also been 
postulated.   Support for leptin related signalling is also provided by the observation 
that we also observed higher circulating leptin concentrations in the HCHO trial when 
compared with both the LCAL (P=0.041) and LCHF trials (albeit P=0.057), an effect 
that is likely secondary to the hyperinsulinemia induced by CHO feeding 
(Kolaczynski et al. 1996; Gonzalez et al. 2019).  In relation to IL-6, Sale et al. (2015) 
reported a strong correlation between changes in IL-6 and βCTX in the post-exercise 
period and therefore postulated that IL-6 may regulate bone turnover via stimulating 
osteoclastogenesis and bone resorption.  It is noteworthy, however, that although we 
observed differences in insulin and leptin between trials, circulating IL-6 was not 
apparently affected by CHO availability. Indeed, the repeated bout of high intensity 
running in PM-HIT significantly increased circulating IL-6 in all three experimental 
conditions, the magnitude of which was greater in LCAL compared to LCHF and 
HCHO. Whilst the effects of muscle glycogen (Steensberg et al. 2001; Keller et al. 
2001; Chan et al. 2004) and exogenous (Nieman et al., 1998; Nieman et al. 2003; 
Febbraio et al. 2003) CHO availability on the regulation of exercise-induced IL-6 
production is well documented, the present data suggest that energy availability plays 
a more dominant regulatory role in mediating IL-6 responses, as compared with CHO 
availability per se.  In contrast, an alternative interpretation is that high fat availability 
in the LCHF trial (despite also being low in absolute CHO content) may have 
suppressed IL-6 production to levels that were comparable to the HCHO trial 
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(Badenhorst et al. 2016; Phillips et al. 2003; DiLorenzo et al. 2014). When taken 
together, the present data suggest that energy availability (but not CHO availability) is 
the more dominant factor in modulating components of cytokine production when 
training under conditions representative of the twice per day train low model. 
Whilst the clinical implications of such acute and transient alterations in bone 
resorption remain to be determined, it would seem sensible for athletes to avoid 
prolonged periods of low CHO availability in order in to reduce the potentially 
detrimental effects on bone mass (Ihle & Loucks, 2004) and/or bone injury risk. The 
findings of the current study might also lend some further support to the requirement 
for post-exercise feeding (particularly of CHO) in order to attenuate the bone 
resorption response to intense exercise or high training volumes. That said, this must 
be carefully considered over time, given that these alterations in bone metabolism are 
also likely to be an important part of the bone adaptive response, which remains an 
area requiring significant future research.  Given the acute nature of this study, we 
were, of course, not able to confirm whether the longer-term adherence to the training 
and dietary regimen studied here would result in morphological changes to bone.  
Indeed, as discussed previously, we were limited to the use of blood borne markers of 
bone metabolism and selected the preferred markers of use as reference analytes for 
bone turnover markers in clinical studies (Vasikaran et al., 2011). Nonetheless, we 
acknowledge that future studies would benefit from the use of scanning techniques 
(e.g., DXA, pQCT or HR-pQCT) or bone biopsy analyses to determine whether our 
chosen exercise and dietary approach does indeed manifest as long-term 
morphological changes to bone.  
In summary, we provide novel data demonstrating that in conditions where post-
exercise muscle glycogen concentration is maintained within the range of 200-350 
mmol·kg-1 dw, short-term periods of acute CHO and energy restriction (i.e., <24 
hours) do not potentiate potent skeletal muscle signalling pathways associated with 
the regulation of mitochondrial biogenesis and lipid metabolism.  In addition, 
promotion of high CHO availability before, during and in recovery from exercise may 
be of greater importance for the acute regulation on markers of bone metabolism 
when compared with energy intake per se. In relation to skeletal muscle adaptation, 
future studies should now examine the potential presence of a muscle glycogen 
threshold as an important regulator of adaptations to endurance training. Additionally, 
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the long-term implications (in relation to other physiological systems) of the acute 
within day fluctuations in both CHO and energy availability inherent to chronic 
training twice per day should also be examined, which would also allow the 
determination of any effects on bone mass and structure using bone scanning 
techniques. 
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Table 1 -  Primer sequences. 
Figure 1 – Overview of the experimental protocol employed in each trial. HIT = 8 x 
5-mins running at a workload equal to 85% VO2peak interspersed by 1-min recovery.  
Figure 2 Heart rate (A&B), CHO oxidation (C&D), lipid oxidation (E&F), and RPE 
(G&H) responses during each HIT bout in the HCHO, LCHF, and LCAL trials. * 
denotes significant difference from HIT bout 1 (P<0.05), # denotes significant 
difference between HCHO and LCHF (P<0.05), $ denotes significant difference 
between HCHO and LCAL (P<0.05). 
Figure 3 Plasma glucose (A), lactate (B), NEFA (C), Glycerol (D), β-OHB (E), and 
insulin (F) before and after the AM-HIT and PM-HIT protocols. * denotes significant 
difference from pre-exercise (P<0.05), # denotes significant difference between 
HCHO and LCHF (P<0.05), $ denotes significant difference between HCHO and 
LCAL (P<0.05). 
 30 
Figure 4 Skeletal muscle glycogen concentration before the AM-HIT and after the 
PM-HIT exercise protocols. * denotes significant difference from pre-exercise 
(P<0.05), # denotes significant difference from HCHO (P<0.05). 
Figure 5 Skeletal muscle phosphorylated p38MAPKT180/Y182 before the AM-HIT and 
after the PM-HIT exercise protocols. * denotes significant difference from pre-
exercise (P<0.05). 
Figure 6 (A) PGC-1 α, (B) p53, (C) SIRT1, (D) Tfam, (E) CPT1, (F) CD36, (G) 
PDK4, and (H) Parkin mRNA before AM-HIT exercise and after PM-HIT exercise.  * 
denotes significant difference from pre-exercise (P<0.05), # denotes significant 
difference from HCHO and LCHF (P<0.05), $ denotes significant difference from 
HCHO (P<0.05). 
Figure 7 Plasma (A) P1NP, (B) βCTX, (C) leptin, (D) ghrelin, (E) IL-6, and (F) 
adiponectin before and after the AM-HIT and PM-HIT protocols. * denotes 
significant difference from pre-exercise (P<0.05), # denotes significant difference 
between HCHO and LCHF (P<0.05), $ denotes significant difference between HCHO 
and LCAL (P<0.05), and a denotes significant difference between LCHF and LCAL 
(P<0.05). 
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Gene Forward sequence Reverse sequence Product 
length 
(bp) 
PGC-1α TGCTAAACGACTCCGAGAA TGCAAAGTTCCCTCTCTGCT 67 
p53 ACCTATGGAAACTACTTCCTGAAA CTGGCATTCTGGGAGCTTCA 141 
Tfam TGGCAAGTTGTCCAAAGAAACCTGT GTTCCCTCCAACGCTGGGCA 135 
PDK4 TGGTCCAAGATGCCTTTGAGT GTTGCCCGCATTGCATTCTT 181 
CPT1 GACAATACCTCGGAGCCTCA AATAGGCCTGACGACACCTG 94 
FAT/CD36 AGGACTTTCCTGCAGAATACCA ACAAGCTCTGGTTCTTATTCACA 199 
SIRT1 CGGAAACAATACCTCCACCT CACATGAAACAGACACCCCA 186 
Parkin TCCCAGTGGAGGTCGATTCT GGAACCCCCTGTCGCTTAG 73 
GAPDH 
(NM_002046.5) 
AAGACCTTGGGCTGGGACTG TGGCTCGGCTGGCGAC 168 
 







